Organigram Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;'>OH</div>
OGI -- USA Stock  

USD 1.74  0.02  1.16%

Organigram Hlds is scheduled to announce its earnings today. The next earnings report is expected on the 13th of April 2021. The stock goes through a very aggressive trading activities. Organigram Hlds Tangible Assets Book Value per Share are most likely to increase slightly in the upcoming years. The last year's value of Tangible Assets Book Value per Share was reported at 3.19. The current Depreciation Amortization and Accretion is estimated to increase to about 22.3 M, while Average Assets are projected to decrease to roughly 453.4 M. As many millenniums are trying to avoid healthcare space, it makes sense to concentrate on Organigram Hlds a little further and try to understand its current market patterns. We will evaluate why recent Organigram Hlds price moves suggest a bounce in February.
Published over a week ago
View all stories for Organigram Hlds | View All Stories
Will Organigram (NASDAQ:OGI) continue to grow in February?
Organigram Hlds has 59.39 M in debt with debt to equity (D/E) ratio of 0.4, which is OK given its current industry classification. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Organigram Hlds has an asset utilization ratio of 23.85 percent. This implies that the company is making $0.24 for each dollar of assets. An increasing asset utilization means that Organigram Hlds is more efficient with each dollar of assets it utilizes for everyday operations.
Organigram Hlds financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of Organigram Hlds, including all of Organigram Hlds's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Organigram Hlds assets, the company is considered highly leveraged. Understanding the composition and structure of overall Organigram Hlds debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business is and if it is worth investing in it. Please read more on our technical analysis page.

How important is Organigram Hlds's Liquidity

Organigram Hlds financial leverage refers to using borrowed capital as a funding source to finance Organigram Hlds ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Organigram Hlds financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Organigram Hlds's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Organigram Hlds, but it might be worth checking our own buy vs. sell analysis

Breaking it down a bit more

The current price rise of Organigram Hlds may encourage stockholders to take a closer look at the company as it is trading at a share price of 1.70 on 11,429,200 in trading volume. The company directors and management may have good odds in positioning the company resources to exploit market volatility in February. The stock standard deviation of daily returns for 30 days investing horizon is currently 6.12. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Organigram Hlds partners.

Asset Breakdown

253.7 M
Assets Non Current
191.9 M
Current Assets
Total Assets445.59 Million
Current Assets191.94 Million
Assets Non Current253.65 Million
Goodwill1.71 Million

Our perspective of the current Organigram Hlds drop

The risk adjusted performance is down to 0.15 as of today. As of the 12th of January 2021, Organigram Hlds holds the Coefficient Of Variation of 703.79, semi deviation of 4.73, and Risk Adjusted Performance of 0.155. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organigram Hlds, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Organigram Hlds, which can be compared to its competitors. Please check Organigram Hlds information ratio, as well as the relationship between the value at risk and expected short fall to decide if Organigram Hlds is priced some-what accurately, providing market reflects its current price of 1.7 per share. Please also confirm Organigram Hlds total risk alpha, which is currently at 0.1406 to check out the company can sustain itself at a future point.

Our Conclusion on Organigram Hlds

While few other entities within the drug manufacturers?specialty & generic industry are still a little expensive, even after the recent corrections, Organigram Hlds may offer a potential longer-term growth to stockholders. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither trade new shares of Organigram nor exit your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Organigram Hlds.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Organigram Hlds. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com